BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

BillionToOne (NASDAQ: BLLN) announced management will participate in the 44th Annual J.P. Morgan Healthcare Conference.

The presentation is scheduled for Monday, January 12, 2026, from 9:45 AM to 10:25 AM PT. A live and archived webcast will be available on BillionToOne's Events & Presentations investor page at https://investors.billiontoone.com/news-events/events-presentations.

Key Figures

Conference edition 44th 44th Annual J.P. Morgan Healthcare Conference

Presentation start time 9:45am Pacific Time Conference presentation window

Presentation end time 10:25am Pacific Time Conference presentation window

Presentation date January 12, 2026 J.P. Morgan Healthcare Conference slot

Market Reality Check

$87.08 Last Close

Volume Volume 126,313 is below 20-day average of 212,120 (relative volume 0.6). low

Technical Price 96.29 trades below 200-day MA at 104.35, about 30.58% below 52-week high 138.7 and 9.42% above 52-week low 88.0001.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 09	Board appointment	Positive	+4.7%	Appointment of experienced CFO Anthony Pagano as Audit Committee Chair.
Dec 09	Earnings results	Positive	+4.7%	Strong Q3 2025 revenue growth, margin expansion and positive operating income.
Dec 02	Earnings date notice	Neutral	+1.7%	Announcement of Q3 2025 results release date and conference call details.
Nov 07	IPO closing	Positive	+2.2%	Closing of upsized IPO and full exercise of underwriters’ option for extra shares.
Nov 06	IPO announcement	Neutral	-8.2%	Law firm announcement detailing BillionToOne’s upsized IPO and bookrunners.

Pattern Detected

Recent positive corporate and earnings news aligned with positive next-day price reactions in 3 observed cases.

Recent Company History

Over the last few months, BillionToOne completed an upsized IPO at $60 per share, raising aggregate gross proceeds of about $314.0M. It subsequently reported strong Q3 2025 results, including total revenue of $83.5M and improved 70% gross margin, with shares rising 4.65% after the announcement. The company also appointed Anthony Pagano as Audit Committee Chair effective January 1, 2026, which coincided with a similar 4.65% move. Today’s conference participation fits into an active post-IPO investor communication phase.

Market Pulse Summary

This announcement highlights BillionToOne’s participation in the 44th Annual J.P. Morgan Healthcare Conference, with management presenting on January 12, 2026. It extends an active period following the company’s IPO, strong Q3 2025 financial results, and a recent board appointment. Investors may focus on how the presentation reinforces the growth story in molecular diagnostics, as well as future updates on revenue trends, margin sustainability, and capital deployment after the IPO proceeds.

Key Terms

molecular diagnostics medical

"a next-generation molecular diagnostics company with a mission to create"

Molecular diagnostics are laboratory tests that look for specific molecules — such as genes, pieces of DNA or RNA, or proteins — to detect disease, predict risk, or guide treatment choices. For investors, these tests matter because they can change how illnesses are diagnosed and treated, create recurring revenue through specialized tests and companion products, and face clear regulatory and reimbursement pathways that drive commercial value; think of them as reading a biological barcode to inform medical decisions.

webcast technical

"A live and archived webcast will be available on the “Events"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44^th Annual J.P. Morgan Healthcare Conference.

Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12^th, 2026.

A live and archived webcast will be available on the “Events & Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.

Investor Contact
ir@billiontoone.com

Media Contact
billiontoone@moxiegrouppr.com

FAQ

When will BillionToOne (BLLN) present at the J.P. Morgan Healthcare Conference?

BillionToOne will present on January 12, 2026 from 9:45 AM to 10:25 AM PT.

How can investors watch the BillionToOne (BLLN) presentation on January 12, 2026?

A live webcast and an archived replay will be available on BillionToOne's Events & Presentations investor page.

Where is the BillionToOne (BLLN) webcast hosted for the J.P. Morgan presentation?

The webcast is hosted on BillionToOne's investor relations site at https://investors.billiontoone.com/news-events/events-presentations.

What time is BillionToOne (BLLN) presenting in Eastern Time on January 12, 2026?

The presentation at 9:45 AM PT corresponds to 12:45 PM ET on January 12, 2026.

Will the BillionToOne (BLLN) J.P. Morgan presentation be available after the event?

Yes, an archived replay will be posted on the company’s Events & Presentations page after the live webcast.